Discovery of novel Ref-1 inhibitors with the ability to block ocular neovascularization Sep. 27, 2018 No Comments
Aldeyra announces positive data from phase IIb study of reproxalap topical ophthalmic solution Sep. 27, 2018 No Comments
Santen and PeptiDream enter ophthalmic multitarget discovery and development agreement Sep. 26, 2018 No Comments
Ribomic evaluating RBM-007 in phase I/II study in exudative age-related macular degeneration Sep. 26, 2018 No Comments
First patient enrolled in phase I study of THR-687 for the treatment of diabetic macular edema Sep. 25, 2018 No Comments
Eybelis granted marketing approval for glaucoma and ocular hypertension in Japan Sep. 25, 2018 No Comments
Oxurion initiates phase II study of THR-317 in macular telangiectasia type 1 Sep. 20, 2018 No Comments
Targeting alpha-4 integrin alleviates allergic conjunctivitis in animal models Sep. 17, 2018 No Comments
RSS